Publication Cover
Accountability in Research
Ethics, Integrity and Policy
Volume 31, 2024 - Issue 1
4,801
Views
7
CrossRef citations to date
0
Altmetric
Research Article

A randomized trial alerting authors, with or without coauthors or editors, that research they cited in systematic reviews and guidelines has been retracted

ORCID Icon, ORCID Icon, & ORCID Icon

References

  • Alfirevic, Z., F. J. Kellie, F. Stewart, L. Jones, and L. Hampson, On behalf of Pregnancy and Childbirth Editorial Board. 2021. Identifying and Handling Potentially Untrustworthy Trials in Pregnancy and Childbirth Cochrane Reviews. Cochrane Pregnancy and Childbirth Group. https://pregnancy.cochrane.org/sites/pregnancy.cochrane.org/files/public/uploads/identifying_and_handling_potentially_untrustworthy_trials_v_2.4_-_20_july_2021.pdf
  • Avenell, A., W. J. Gillespie, L. D. Gillespie, and D. L. O’Connell. 2009. “Vitamin D and Vitamin D Analogues for Preventing Fractures Associated with Involutional and Post-Menopausal Osteoporosis (Third Update).” The Cochrane Database of Systematic Reviews (2). Art. No.: CD000227. doi:10.1002/14651858.CD000227.pub3.
  • Avenell, A., F. Stewart, A. Grey, G. Gamble, and M. Bolland. 2019. “An Investigation into the Impact and Implications of Published Papers from Retracted Research: Systematic Search of Affected Literature.” BMJ Open 9: e031909. doi:10.1136/bmjopen-2019-031909.
  • Bolland, M. J., A. Avenell, G. D. Gamble, and A. Grey. 2016. “Systematic Review and Statistical Analysis of the Integrity of 33 Randomized Controlled Trials.” Neurology 87: 2391–2402. doi:10.1212/WNL.0000000000003387.
  • Bolland, M. J., A. Grey, and A. Avenell. 2022. “Citation of Retracted Publications: A Challenging Problem.” Accountability in Research 29: 18–25. doi:10.1080/08989621.2021.1886933.
  • Candal-Pedreira, C., A. Ruano-Ravina, E. Fernández, J. Ramos, I. Campos-Varela, and M. Pérez-Ríos. 2020. “Does Retraction after Misconduct Have an Impact on Citations? A Pre–Post Study.” BMJ Global Health 5: e003719. doi:10.1136/bmjgh-2020-003719.
  • Cochrane Editorial and Publishing Policy Resource. 2022. https://documentation.cochrane.org/display/EPPR/Policy+for+managing+potentially+problematic+studies%3A+implementation+guidance
  • Committee on Publication Ethics. November 2019. “Retraction Guidelines—English.” Version 2, doi:10.24318/cope.2019.1.4.
  • Cosentino, A. M., and D. Veríssimo. 2016. “Ending the Citation of Retracted Papers.” Conservation Biology 30: 676–678. doi:10.1111/cobi.12676.
  • Fanelli, D., J. Wong, and D. Moher. 2021. “What Difference Might Retractions Make? an Estimate of the Potential Epistemic Cost of Retractions on Meta-Analyses.” Accountability in Research 1–18. doi:10.1080/08989621.2021.1947810.
  • Fu, Y., and J. Schneider. 2020. “Towards Knowledge Maintenance in Scientific Digital Libraries with the Keystone Framework.” Proceedings of the ACM/IEEE Joint Conference on Digital Libraries in 2020 (JCDL ’20), 10. New York, NY, USA: ACM. doi:10.1145/3383583.3398514.
  • Gillespie, L. D., M. C. Robertson, W. J. Gillespie, C. Sherrington, S. Gates, L. Clemson, and S. E. Lamb. 2012. “Interventions for Preventing Falls in Older People Living in the Community.” Cochrane Database of Systematic Reviews (9). Art. No.: CD007146. doi:10.1002/14651858.CD007146.pub3.
  • Grey, A., M. J. Bolland, A. Avenell, A. A. Klein, and C. K. Gunsalus. 2020. “Check for Publication Integrity before Misconduct.” Nature 577: 167–169. doi:10.1038/d41586-019-03959-6.
  • Grey, A., A. Avenell, and M. Bolland. 2021. “Timeliness and Content of Retraction Notices for Publications by a Single Research Group: An Observational Study.” Accountability in Research 1–32. doi:10.1080/08989621.2021.1920409.
  • Gross, R. A. 2016. “Statistics and the Detection of Scientific Misconduct.” Neurology 87: 2388. doi:10.1212/WNL.0000000000003390.
  • Hamilton, D. G. 2019. “Continued Citation of Retracted Radiation Oncology Literature – Do We Have a Problem?” International Journal of Radiation Oncology, Biology and Physics 5: 1036–1042. doi:10.1016/j.ijrobp.2018.11.014.
  • Healthcare Improvement Scotland. 2015. “SIGN guideline 142.” Management of Osteoporosis and the Prevention of Fragility Fractures, https://www.sign.ac.uk/our-guidelines/
  • Herrmann, M., J. P. Schmidt, N. Umanskaya, A. Wagner, O. Taban-Shomal, T. Widmann, G. Colaianni, B. Wildemann, and W. Herrmann. 2007. “The Role of Hyperhomocysteinemia as Well as Folate, Vitamin B(6) and B(12) Deficiencies in Osteoporosis - a Systematic Review.” Clinical Chemistry and Laboratory Medicine 45: 1621–1632. [Erratum in Herrmann, M., J. P. Schmidt, N. Umanskaya, A. Wagner, O. Taban-Shomal, T. Widmann, G. Colaianni, B. Wildemann, and W. Herrmann. Corrigendum to: “The Role of Hyperhomocysteinemia as Well as Folate, Vitamin B6 and B12 Deficiencies in Osteoporosis - a Systematic Review.” 2021. Clinical Chemistry and Laboratory Medicine 59: 455. 10.1515/cclm-2020-1684]. doi:10.1515/CCLM.2007.362.
  • Higgins, J. P. T., D. G. Altman, P. C. Gøtzsche, P. Jüni, D. Moher, A. D. Oxman, J. Savovic, K. F. Schulz, L. Weeks, J. A. C. Sterne, et al. 2011. “The Cochrane Collaboration’s Tool for Assessing Risk of Bias in Randomised Trials.” BMJ 343:d5928. doi:10.1136/bmj.d5928.
  • International Committee of Medical Journal Editors. “Preparing a Manuscript for Submission to a Medical Journal.” Accessed 3rd February 2022. http://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html
  • Invernizzi, M., S. Carda, G. S. Viscontini, and C. Cisari. 2009. “Osteoporosis in Parkinson’s Disease.” Parkinsonism and Related Disorders 15: 339–346. doi:10.1016/j.parkreldis.2009.02.009.
  • Jadad, A. R., R. A. Moore, D. Carroll, C. Jenkinson, D. J. Reynolds, D. J. Gavaghan, and H. J. McQuay. 1996. “Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary?” Controlled Clinical Trials 17: 1–12. doi:10.1016/0197-2456(95)00134-4.
  • Kataoka, Y., M. Banno, Y. Tsujimoto, T. Ariie, S. Taito, T. Suzuki, S. Oide, T. A. Furukawa . 2022. “The Impact of Retracted Randomised Controlled Trials on Systematic Reviews and Clinical Practice Guidelines: A meta-epidemiological Study.” medRxiv Preprint. doi:10.1101/2022.01.30.22270124.
  • Kernan, W. N., B. Ovbiagele, H. R. Black, D. M. Bravata, M. I. Chimowitz, M. D. Ezekowitz, M. C. Fang, M. Fisher, K. L. Furie, D. V. Heck, et al. 2014. “Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack. A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association.” Stroke 45:2160–2236. doi:10.1161/STR.0000000000000024.
  • Loadsman, J. A. 2019. “Why Does Retraction Take So Much Longer Than Publication?” Anaesthesia 74: 3–5. doi:10.1111/anae.14484.
  • McCarus, D. C. 2006. “Fracture Prevention in Postmenopausal Osteoporosis: A Review of Treatment Options.” Obstetrical & Gynecological Survey 61: 39–50. [Notice to readers. 2021. Obstetrical and Gynecological Survey 76: 36]. doi:10.1097/01.ogx.0000197807.08697.06.
  • Mott, A., C. Fairhurst, and D. Torgerson. 2019. “Assessing the Impact of Retraction on the Citation of Randomized Controlled Trial Reports: An Interrupted Time-Series Analysis.” Journal of Health Services Research & Policy 24: 44–51. doi:10.1177/1355819618797965.
  • Murad, M. H., K. B. Elamin, N. O. Abu Elnour, M. B. Elamin, A. A. Alkatib, M. M. Fatourechi, J. P. Almandoz, R. J. Mullan, M. A. Lane, H. Liu, et al. 2011. “The Effect of Vitamin D on Falls: A Systematic Review and Meta-Analysis.” Journal of Clinical Endocrinology & Metabolism 96: 2997–3006. [Murad, M. H. 2021. Letter to the Editor from Murad: “The Effect of Vitamin D on Falls: A Systematic Review and Meta-Analysis.” Journal of Clinical Endocrinology & Metabolism 106: e1495. 10.1210/clinem/dgaa928]. doi:10.1210/jc.2011-1193.
  • Murad, M. H., M. T. Drake, R. J. Mullan, K. F. Mauck, L. M. Stuart, M. A. Lane, O. Nisrin, P. J. Erwin, A. Hazem, M. A. Puhan, et al. 2012. “Comparative Effectiveness of Drug Treatments to Prevent Fragility Fractures: A Systematic Review and Network Meta-Analysis.” Journal of Clinical Endocrinology & Metabolism 97: 1871–1880. [Murad, M. H. 2021. Letter to the Editor From Murad: “Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: a Network Meta-Analysis.” Journal of Clinical Endocrinology & Metabolism 106: e1494. 10.1210/clinem/dgaa933]. doi:10.1210/jc.2011-3060.
  • Peterson, A. L. 2014. “A Review of Vitamin D and Parkinson’s Disease.” Maturitas 78: 40–44. [Letter in Hiller, A. 2021. Response to the Retraction of Papers by Yoshihiro Sato - a Review of Vitamin D and Parkinson’s Disease.” Maturitas 148: 54. 10.1016/j.maturitas.2021.03.010]. doi:10.1016/j.maturitas.2014.02.012.
  • “Physiotherapy Evidence Database.” PEDro Scale, Accessed 17th January 2022. https://pedro.org.au/english/resources/pedro-scale/
  • PRISMA. 2020. http://www.prisma-statement.org/PRISMAStatement/Checklist.aspx
  • Qaseem, A., V. Snow, P. Shekelle, R. Hopkins, M. A. Forciea, and D. K. Owens, For the Clinical Efficacy Assessment Subcommittee of the American College of Physicians. 2008. “Pharmacologic Treatment of Low Bone Density or Osteoporosis to Prevent Fractures: A Clinical Practice Guideline from the American College of Physicians.” Annals of Internal Medicine 149: 404–415. [Letter in Qaseem, A., and T. J. Wilt. 2021. “Treatment of Low Bone Density or Osteoporosis to Prevent Fractures.” Annals of Internal Medicine 174: 1191-2. 10.7326/L21-0434.]. doi:10.7326/0003-4819-149-6-200809160-00007.
  • Qaseem, A., M. A. Forciea, R. M. McLean, and T. D. Denberg, For the Clinical Guidelines Committee of the American College of Physicians. 2017. “Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update from the American College of Physicians.” Annals of Internal Medicine 166: 818–839. [Letter in Qaseem, A., and T. J. Wilt. 2021. “Treatment of Low Bone Density or Osteoporosis to Prevent Fractures.” Annals of Internal Medicine 174: 1191-2. 10.7326/L21-0434.]. doi:10.7326/M15-1361.
  • Retraction Watch Database. New York: Center for Scientific Integrity. 2018. http://retractiondatabase.org/
  • Schneider, J., N. D. Woods, R. Proescholdt, and Y. Fu, The RISRS Team. July 2021. “Recommendations from the Reducing the Inadvertent Spread of Retracted Science: Shaping a Research and Implementation Agenda Project.” MetaArXiv Preprints Accessed 25 January 2022. doi:10.31222/osf.io/ms579.
  • Sox, H. C., and D. Rennie. 2006. “Research Misconduct, Retraction, and Cleansing the Medical Literature: Lessons from the Poehlman Case.” Annals of Internal Medicine 144: 609–613. doi:10.7326/0003-4819-144-8-200604180-00123.
  • Steen, R. G. 2011. “Retractions in the Medical Literature: How Many Patients are Put at Risk by Flawed Research?” Journal of Medical Ethics 37: 688–692. doi:10.1136/jme.2011.043133.
  • Steen, R. G. 2012. “Retractions in the Medical Literature: How Can Patients Be Protected from Risk?” Journal of Medical Ethics 38: 228–232. doi:10.1136/medethics-2011-100184.
  • The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. 2008. “Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008.” Cerebrovascular Diseases 25:457–507. doi:10.1159/000131083.
  • Tricco, A. C., S. M. Thomas, A. A. Veroniki, J. S. Hamis, E. Cogo, L. Strifler, P. A. Khan. 2017. “Comparisons of Interventions for Preventing Falls in Older Adults. A Systematic Review and Meta-Analysis.” JAMA Intern Med 318:1687–1699. doi:10.1001/jama.2017.15006.
  • van der Vet, P. E., and H. Nijveen. 2016. “Propagation of Errors in Citation Networks: A Study Involving the Entire Citation Network of a Widely Cited Paper Published In, and Later Retracted From, the Journal Nature.” Research Integrity and Peer Review 1: 3. doi:10.1186/s41073-016-0008-5.
  • Zhang, W., C. Zhu, M. Sun, Y. Ge, and G. Yan. 2014. “Efficacy of Bisphosphonates against Hip Fracture in Elderly Patients with Stroke and Parkinson Diseases: Meta-Analysis of Randomized Controlled Trials.” Journal of Stroke & Cerebrovascular Diseases 23: 2714–2724. [Retraction in Zhang, W., C. Zhu, M. Sun, Y. Ge, and G. Yan. 2021. Journal of Stroke & Cerebrovascular Diseases 30: 105682. 10.1016/j.jstrokecerebrovasdis.2021.105682]. doi:10.1016/j.jstrokecerebrovasdis.2014.06.022.
  • Zhong, Z. M., and J. T. Chen. 2009. “Anti-Fracture Efficacy of Risedronic Acid in Men. A Meta-Analysis of Randomized Controlled Trials.” Clinical Drug Investigation 29: 349–357. [Retraction in Zhong, Z. M., and J. T. Chen. 2021. Clinical Drug Investigation 41: 199. 10.1007/s40261-020-00999-z.].doi:10.2165/00044011-200929050-00007.